Note: This article is for informational purposes only and reflects current U.S. guidance. People with rheumatic diseases should confirm vaccine timing with their rheumatologist and primary care clinician, especially if they take methotrexate, rituximab, high-dose steroids, biologics, or JAK inhibitors.
If you live with a rheumatic disease, your immune system is already doing interpretive dance when you really wanted a calm waltz. Add immunosuppressive medication to the mix, and suddenly flu season and pneumococcal infections are not just annoying seasonal guests. They are potential troublemakers.
That is why updated vaccination guidance matters so much. In the United States, the latest picture now combines two important layers: the American College of Rheumatology guidance for people with rheumatic and musculoskeletal diseases, and newer CDC adult vaccine schedules that have changed how pneumococcal vaccines are used. Together, they create a clearer playbook for people with rheumatoid arthritis, lupus, psoriatic arthritis, ankylosing spondylitis, vasculitis, and related conditions.
The short version is reassuring. The flu shot is still strongly encouraged every year. Pneumococcal vaccination is now easier to understand than the old alphabet soup suggested, although it still helps to have a clinician decode your vaccine history. And if you are on medications such as methotrexate or rituximab, timing matters more than ever.
What the Updated Guidance Really Means
The biggest update is not that doctors suddenly discovered vaccines are useful. Thankfully, that memo was already sent. The real change is that recommendations are more specific about which vaccine to use, when to use it, and how to work around immunosuppressive therapy.
For influenza, the guidance remains firm: people with rheumatic diseases should get vaccinated every year. For pneumococcal disease, the CDC now uses newer conjugate vaccines in adults, including PCV15, PCV20, and PCV21. That is a meaningful shift from the older era when many patients were juggling PCV13 and PPSV23 schedules that felt like a pop quiz no one studied for.
For rheumatology patients, the updated message is this: do not treat vaccination like an optional side quest. It is part of disease management. Preventing infection is not separate from treating arthritis, lupus, or autoimmune inflammation. It is one of the smartest ways to protect joints, lungs, energy levels, and the ability to stay on treatment.
Why People With Rheumatic Diseases Need Extra Protection
People with rheumatic diseases are more vulnerable to infection for two reasons. First, many autoimmune and inflammatory conditions can affect how the immune system works. Second, the medications used to control inflammation often suppress the immune response on purpose. That is great when the goal is calming an overactive immune system. It is less great when the goal is fighting off flu or invasive pneumococcal disease.
This does not mean vaccines work poorly across the board. It means they become more important, and sometimes more strategic. Doctors may need to choose the right vaccine product, schedule it at the right time, or briefly adjust a medication plan to improve the immune response.
It also means that the term “pneumonia vaccine” deserves a quick translation. Most of the time, what people mean is the pneumococcal vaccine, which protects against infections caused by Streptococcus pneumoniae. It helps reduce the risk of certain bacterial pneumonias and other serious pneumococcal diseases, but it does not prevent every type of pneumonia. Think of it as important protection, not a magic force field.
Updated Flu Vaccine Guidance for Rheumatic Disease
Get a flu vaccine every year
The flu recommendation is simple and strong: annual vaccination remains the standard. If you have a rheumatic disease, skipping the flu shot because you are waiting for the “perfect” moment is usually the wrong move. The current rheumatology guidance says seasonal influenza vaccination should still be given even when disease activity is high, even when a patient is taking high-dose glucocorticoids, and even when the patient is receiving rituximab.
That matters because many patients assume they should wait until everything is calm. Unfortunately, the flu does not wait for your chart to look neat.
Which flu vaccine is best?
For the current U.S. flu season, vaccines are trivalent, meaning they are designed to protect against three expected flu strains. Adults should receive an age- and health-appropriate product. For many patients with rheumatic disease, an inactivated flu shot or recombinant flu vaccine is the go-to choice.
If you are immunocompromised, the live intranasal flu vaccine is generally not the right pick. That is the one delivered through the nose rather than the arm. It may sound convenient, but convenience loses this round.
There is also a nuance here that patients often miss. The American College of Rheumatology conditionally favors high-dose or adjuvanted influenza vaccine for adults age 65 and older, and even for adults 18 to 64 who are taking immunosuppressive medication. Still, if that specific product is not available, a standard-dose flu shot should not be delayed. The best vaccine is the one that gets into your arm while the appointment is still happening.
Medication timing matters
The most talked-about medication adjustment is methotrexate. Current rheumatology guidance says methotrexate may be held for two weeks after the flu vaccine if disease activity allows. The point is to improve vaccine response without causing a flare. This is not a DIY project, though. It should be a clinician-guided decision based on how stable your disease is.
Rituximab is the other big scheduling issue. For influenza, the guidance says not to delay the flu vaccine just because rituximab is on board. Give the flu vaccine on schedule. For other non-live vaccines, timing them closer to when the next rituximab dose is due may improve the immune response, and rituximab is often delayed for at least two weeks after vaccination if possible.
For most other immunosuppressive medications, non-live vaccines are usually given without stopping the drug. In other words, methotrexate and rituximab get the dramatic headlines, but many other medications do not require a major scheduling dance.
Updated Pneumococcal Vaccine Guidance for Rheumatic Disease
Who needs pneumococcal vaccination?
This is where the updated CDC schedule becomes especially relevant. Adults age 50 and older are now included in routine age-based pneumococcal vaccination recommendations. In addition, younger adults ages 19 through 49 may need pneumococcal vaccination if they have certain risk conditions, including immunocompromising conditions or iatrogenic immunosuppression. That matters for many people treated for rheumatic disease.
The American College of Rheumatology goes a step further for its own population: pneumococcal vaccination is strongly recommended for people younger than 65 who have rheumatic disease and are taking immunosuppressive medication.
The current vaccine options
Today’s main adult options are:
- PCV20 as a single-dose conjugate vaccine
- PCV21 as a single-dose conjugate vaccine
- PCV15 followed by PPSV23
If PCV15 is used, PPSV23 is typically given one year later. In adults with immunocompromising conditions, a shorter minimum interval may be considered in some cases. If PCV20 or PCV21 is used, no additional pneumococcal vaccine dose is generally needed afterward.
That is the cleaner, newer framework. It is far easier than the old vaccine history scavenger hunt, although not every adult starts from scratch.
What if you had an older pneumonia shot years ago?
This is where people start saying things like, “I got a pneumonia shot once… maybe before the pandemic… or maybe after a dental cleaning?” and everybody in the room sighs gently.
If you previously received PCV13 or PPSV23, your next step depends on exactly what you got and when you got it. The updated CDC approach often uses the newer conjugate vaccines, including PCV20 or PCV21, to complete protection. In plain English: old vaccine history does not necessarily mean you are fully done forever. It means your clinician may need to reconstruct the timeline.
Bring your vaccine record if you have it. If you do not, bring your best detective energy and the name of the pharmacy or clinic that gave the shot.
How Disease Activity and Medications Affect the Plan
Active disease is not an automatic stop sign
One of the most useful parts of current rheumatology guidance is the reminder that vaccination should not be postponed just because disease is active. Non-live vaccines can generally still be given. That is especially true for influenza, where seasonal timing matters.
Steroids need special thought
Glucocorticoids complicate life in the way only steroids can. Current guidance says influenza vaccine should still be given even when patients are on high-dose prednisone. For other non-live vaccines, clinicians may sometimes wait until the steroid dose is lower if the patient is taking the equivalent of prednisone 20 mg per day or more and the situation allows it.
This is why blanket rules fail. One patient may need vaccination now because the respiratory virus season is already here. Another may be able to wait a few weeks for a better immune response. Same vaccine category, different real-life decision.
Biologics and JAK inhibitors
Patients taking biologics or targeted therapies often worry that vaccines will either cause a flare or “not work.” The truth is less dramatic and more practical. Most non-live vaccines are considered safe, but the immune response can be reduced by some treatments. That is why timing and product choice matter. It is also why live vaccines are usually deferred in patients receiving significant immunosuppression.
Common Questions Patients Still Ask
Can the flu shot give me the flu?
No. The injectable flu vaccines used for most adults with rheumatic disease do not cause influenza. You can feel achy or tired afterward because your immune system is reacting, not because the vaccine snuck in and started a tiny flu rebellion.
Do vaccines trigger flares?
Most non-live vaccines are considered safe in rheumatic disease, and the benefit of preventing serious infection usually outweighs the risk of temporary side effects. A sore arm and one grumpy day are usually a far better bargain than pneumonia.
Can I get vaccinated at the pharmacy?
Often, yes. Pharmacies have become a major access point for flu and pneumococcal vaccination. But for patients on complex medication schedules, especially rituximab or methotrexate, it is smart to coordinate with the rheumatology team before rolling up a sleeve.
A Practical Vaccine Checklist for Rheumatology Patients
- Ask your clinician whether you are considered immunosuppressed based on your disease and medication list.
- Get a flu vaccine every year, ideally before flu activity peaks in your community.
- Use an inactivated or recombinant flu vaccine rather than the live intranasal version if you are immunocompromised.
- Review whether you need PCV20, PCV21, or PCV15 followed by PPSV23.
- Tell your doctor if you take methotrexate, rituximab, prednisone, a biologic, or a JAK inhibitor.
- Bring any old vaccine records to appointments. Your future self will be grateful.
- Do not skip vaccination just because disease activity is not perfect. Ask about the best timing instead.
Real-World Experiences With the Updated Guidance
One reason these updated recommendations matter is that they match what actually happens in clinics. Real life is messy. Medication lists are long. Vaccine histories are fuzzy. And patients are usually juggling work, fatigue, flares, insurance, and the small inconvenience of being human.
Consider a common composite scenario: a woman in her 40s with rheumatoid arthritis is stable on methotrexate and hears from her pharmacy that flu shots are available. Her first instinct is to wait until she talks to rheumatology because she has heard mixed advice online. The updated guidance gives her and her clinicians a much clearer answer. She should get the flu vaccine, and if her disease is stable, her team may decide to hold methotrexate for two weeks afterward to improve the response. Instead of vague panic, there is a plan.
Another composite patient is a man with ANCA-associated vasculitis receiving rituximab. He assumes all vaccines should wait until months after treatment. That would be understandable, but not fully correct. With influenza, current guidance says not to miss seasonal vaccination just because rituximab is in the picture. For pneumococcal and other non-live vaccines, the timing may be adjusted to improve response, often by lining vaccination up near the next rituximab due date and then postponing the infusion briefly if disease control allows. That is a very different message from “wait indefinitely.”
Then there is the patient with psoriatic arthritis who says, “I had a pneumonia shot years ago, so I’m covered forever, right?” Not necessarily. Under newer CDC schedules, prior vaccination history may still leave room for an updated conjugate vaccine. In practice, this leads to a surprising number of chart reviews, pharmacy phone calls, and relieved patients who realize the rules are more modern and more protective than they used to be.
Older adults with rheumatic disease also have a more refined decision tree now. A 68-year-old with lupus may need both a yearly flu shot and a pneumococcal vaccine review, but the flu conversation now includes whether an enhanced product such as high-dose, recombinant, or adjuvanted vaccine is the better match for age and immune status. Patients often appreciate that this is no longer just “get a flu shot” but “get the right flu shot if possible.” That feels more tailored, because it is.
Clinicians also report that the updated framework helps with confidence. Primary care doctors, rheumatologists, pharmacists, and nurses are better able to say, “Here is what you need now, here is what can wait, and here is what your medication changes.” That matters because vaccine hesitancy in autoimmune disease is often not ideological. It is logistical. Patients are not saying no to protection. They are saying they are confused.
And that may be the most important real-world experience of all. When guidance gets clearer, patients are more likely to follow through. They stop worrying that a flu shot will wreck their disease control. They stop assuming a sore arm means something went wrong. They stop guessing whether “pneumonia vaccine” means something they had ten years ago or something they need now. Updated guidelines do not remove every gray area, but they do replace a lot of shrugging with a lot more certainty.
Bottom Line
The updated flu and pneumococcal vaccine guidance for people with rheumatic diseases is ultimately about smarter prevention. Annual flu vaccination remains essential. Pneumococcal vaccination is now organized around newer adult options such as PCV15, PCV20, and PCV21. Medication timing matters, especially with methotrexate and rituximab. And perhaps most importantly, waiting for a perfect moment is usually less helpful than making a good, well-timed plan.
If you live with a rheumatic disease, ask your healthcare team one simple question at your next visit: Am I up to date on flu and pneumococcal vaccination based on my age, diagnosis, and medication list? It is one of the highest-value questions you can ask, and unlike some parts of medicine, it has an answer that can actually be written down on one page.
